References from Beyond venetoclax and azacitidine: CD70-targeted triplet therapy in acute myeloid leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Beyond venetoclax and azacitidine: CD70-targeted triplet therapy in acute myeloid leukemia | ResearchHub - ResearchHub
